Elevance Health Inc reports results for the quarter ended June 30 - Earnings Summary

• Elevance Health Inc ELV reported quarterly adjusted earnings of $8.84​​ per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of $10.12. The mean expectation of twenty analysts for the quarter was for earnings of $8.95 per share. Wall Street expected results to range from $8.59 to $9.98 per share.

• Revenue rose 14.3% to $49.42 billion from a year ago; analysts expected $48.23 billion.

• Elevance Health Inc's reported EPS for the quarter was $7.72​.

• The company reported quarterly net income of $1.74 billion.

• Elevance Health Inc shares had fallen by 11.4% this quarter and lost 6.6% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 9.1% in the last three months.​

• In the last 30 days, six analysts negatively revised earnings estimates

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 17 "strong buy" or "buy," 7 "hold" and no "sell" or "strong sell." The average consensus recommendation for the managed healthcare peer group is also "buy"

• Wall Street's median 12-month price target for Elevance Health Inc is $478.00, about 27.9% above its last closing price of $344.55

This summary was machine generated from LSEG data July 17 at 11:01 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)